Drug
Gadolinium-Chelate
Gadolinium-Chelate is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
100%(1 trials)
Phase Distribution
Ph phase_2
2
50%
Ph not_applicable
2
50%
Phase Distribution
0
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(1)
Other(2)
Detailed Status
unknown2
Completed1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 22 (50.0%)
N/A2 (50.0%)
Trials by Status
completed125%
recruiting125%
unknown250%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_2
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
NCT06319027
completednot_applicable
Advanced MRI Scan Before and After Radiation Therapy for the Detection of Intracranial Metastasis
NCT04870645
unknownphase_2
Dutasteride in Treating Patients With Prostate Cancer
NCT01193855
unknownnot_applicable
Multifunctional Magnetic Resonance Imaging in Predicting Breast Lesions in Women Undergoing Mastectomy for Breast Cancer
NCT00602316
Clinical Trials (4)
Showing 4 of 4 trials
NCT06319027Phase 2
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
NCT04870645Not Applicable
Advanced MRI Scan Before and After Radiation Therapy for the Detection of Intracranial Metastasis
NCT01193855Phase 2
Dutasteride in Treating Patients With Prostate Cancer
NCT00602316Not Applicable
Multifunctional Magnetic Resonance Imaging in Predicting Breast Lesions in Women Undergoing Mastectomy for Breast Cancer
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4